WEDNESDAY, April 26, 2023 (HealthDay News) — An extended-release version of a Parkinson’s disease drug could provide more stable relief for patients with the movement disorder, new clinical trial data show. The new formulation of levodopa, called IPX203, extended the duration of patients’ “on time” — the amount of timeContinue Reading

TUESDAY, April 25, 2023 (HealthDay News) — Each year, about 140 kids in the United States are diagnosed with a craniopharyngioma, a typically non-cancerous brain tumor that develops near the pituitary gland at the base of the brain. Doctors treat craniopharyngiomas with surgery to remove the entire tumor or aContinue Reading

MONDAY, April 24, 2023 (HealthDay News) — Sciatica can send searing, unrelenting pain down your legs, and surgery is often recommended if other less invasive measures fail to bring relief. Unfortunately, a new study review suggests that such operations likely only provide temporary results, with pain typically returning within aContinue Reading

MONDAY, April 24, 2023 (HealthDay News) — When exercise studies are led by men, female participants are often in short supply. While this underrepresentation of female research subjects has been documented in everything from clinical trials to cell cultures, a new study links researchers’ gender and women’s participation. “Our findingsContinue Reading